Giving intravenous therapy to children at home is costly, lowers parents' quality of life
(University of Utah Health) When treating patients, doctors sometimes overlook how their decisions impact a world they never see: a patient's home life. In the case of some serious infections in children, oral antimicrobial drugs are just as good at treating these ailments at home as the standard, intravenous medications. But according to new research led by investigators at University of Utah Health, by-mouth medications excel in the important measure of preserving parents' quality of life. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 25, 2019 Category: Infectious Diseases Source Type: news

Clinical Nurse Specialist- Endocrinology
Vacancies for Band 7 Senior Clinical Nurse Specialists in Endocrinology (QEHB and HGS) at University Hospitals Birmingham NHS Foundation Trust.Salary:£33,222-£43,041Interview date expected to be10 April 2019Two exciting opportunities have arisen for individuals to contribute towards the provision of excellent patient care within our Endocrinology and Diabetes Service. We are looking to appointment two Senior Clinical Nurse Specialists in Endocrinology. One post will be for our Heartlands, Good Hope and Solihull Hospital site (HGS) and the other for our Queen Elizabeth Hospital Birmingham(QEHB) ...
Source: Society for Endocrinology - March 18, 2019 Category: Endocrinology Source Type: news

Celebrities help the £500 vitamin jab go mainstream
Intravenous therapy has taken off via social media after star names led the way. But its effects are unknown, doctors warnMadonna does it. Rihanna ’s done it. Katy Perry, Rita Ora and Gwyneth Paltrow have been known to dabble and while there are no clinical studies to prove the benefits of intravenous vitamin therapy, the celebrity wellness trend appears to have gone fully mass market.In a gleaming west London clinic, with plump leather recliners and a TV tuned to Netflix, Yassine Bendiabdallah explains the benefits of his IV treatments. Customers, mostly wealthy and mostly women, visit him for courses of injections prom...
Source: Guardian Unlimited Science - March 3, 2019 Category: Science Authors: Nosheen Iqbal Tags: Health & wellbeing Nutrition Science UK news Society Source Type: news

FDA: West Pharma recall of Vial2Bag fluid transfer systems is Class I
The FDA recently labeled a select recall of West Pharmaceutical Services‘ (NYSE:WST) Vial2Bag fluid transfer systems over device functionality issues as Class I. Class I designations, the FDA’s most severe, are used when there is a reasonable probability that product use could cause serious adverse health consequences of death. The West Whiteland Township, Penn.-based company’s Vial2Bag fluid transfer systems are designed to connect a vial containing medication to an intravenous therapy bag to aid in mixing the medication with the IV fluids, according to an FDA release. Read the whole story on our sister site, D...
Source: Mass Device - February 4, 2019 Category: Medical Devices Authors: Fink Densford Tags: Drug Pumps Featured Food & Drug Administration (FDA) Recalls West Pharmaceutical Services Inc. Source Type: news

Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia
This journal article covering a cohort study (n=2,161) found no mortality difference with oral step down within 5 days vs continued IV antibiotics (13.1% vs 13.4%, p>0.05). There was also no difference in bacteraemia recurrence, and patients given step down treatment were discharge on average 2 days sooner. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 24, 2019 Category: Consumer Health News Source Type: news

Is IV therapy a 2019 wellness trend you need to try?
IV clinics are popping up in cities and towns across the country. (Source: ABC News: Health)
Source: ABC News: Health - January 15, 2019 Category: Consumer Health News Tags: GMA Source Type: news

State takes action against physician, chiropractor involved with Overland Park IV clinic
The Kansas Board of Healing Arts has issued orders restricting an area physician and chiropractor from practicing in an Overland Park IV clinic. The board issued emergency orders temporarily restricting Dr. Angela Garner and chiropractor Tara Zeller from practicing with IV Nutrition Clinic or any substantially similar IV therapy clinic until further licensing hearings can be held. Brian Niceswanger, an Evans& Dixon LLC lawyer representing Garner and Zeller, said the two have a hearing scheduled … (Source: Health Care:Pharmaceuticals headlines)
Source: Health Care:Pharmaceuticals headlines - December 31, 2018 Category: Pharmaceuticals Source Type: news

Applying Quality Management Best Practices for Medtech
Conclusion Today's medical device manufacturers are in a race every day to improve compliance, quality, and production scale and speed so they can retain customers and win new ones. Being able to simultaneously compete across these conflicting dimensions of their business makes real-time monitoring essential for providing an accurate, continual data stream that powers analytics and BI applications for insights into improvement. Compliance and quality require exceptional data accuracy and precision to generate the reports and ongoing regulatory filings essential for selling into various countries and industries around the w...
Source: MDDI - October 17, 2018 Category: Medical Devices Authors: Anthony Parise and Louis Columbus Tags: Regulatory and Compliance Source Type: news

ivWatch Finds Strong Ally in Philips to Monitor Peripheral IVs
When it comes to peripheral intravenous (IV) therapy, doctors and nurses have come to accept that things might not go smoothly. Nearly 80% of hospital patients in the U.S. receive an IV — a procedure that has a startling 50% fail rate. ivWatch, the only provider of continuous non-invasive monitoring devices that can detect IV infiltrations and extravasations, hopes to curb those numbers after announcing that their devices will now be compatible with Philips Intellivue Patient Monitors. “For too long IV infiltration has been an accepted outcome of peripheral intravenous therapy,” says Gary Warren, president and CEO o...
Source: MDDI - July 5, 2018 Category: Medical Devices Authors: Kristopher Sturgis Tags: IV Products Source Type: news

How I convince the needle-wary to try IV therapy
RecoverMD in Timonium offers IV therapy to the hungover as well as those just feeling sick and dehydrated. (Source: Health Care:Physician Practices headlines)
Source: Health Care:Physician Practices headlines - May 11, 2018 Category: American Health Authors: Morgan Eichensehr Source Type: news

What Causes Hyponatremia?
Discussion Normal kidneys regulate water balance to maintain a plasma osmolality of 275-290 mOsm/kg normally. Thirst and arginine vasopressin or antidiuretic hormone (ADH) are the primary regulators of plasma osmolality. ADH is made in the hypothalamus and released by the posterior pituitary gland. ADH acts on the kidney’s distal collecting duct to increase water reabsorption. ADH is appropriately released in hypovolemic states, such as dehydration caused by gastroenteritis. ADH has an ~10 minute half-life and therefore can respond to rapid changes in volume status. Sodium balance is regulated by aldosterone (as part...
Source: - April 23, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

I ’m an Engineer, But I Can’t Fix Stupid
“You can’t fix stupid,” a phrase I’ve heard engineers use about consumers, can and should be applied to medical device companies that refuse to adapt to customer needs. Consumers lead enterprise, and healthcare must start thinking like the consumer-oriented market we are becoming and develop products that are stupid simple to use. Some of us are regular consumers of the healthcare system, but more often than not, most people, especially younger generations, have infrequent interactions with the healthcare system because they don’t have to make significant decisions related to their well-being. As this group ages,...
Source: MDDI - March 29, 2018 Category: Medical Devices Authors: Gary Warren Tags: Design Source Type: news

Make the Diagnosis: Itchy Fingers from IV Therapy?
(MedPage Today) -- Case Findings: A 48-year-old woman who was receiving IV immunoglobulin therapy complained to her doctor that over the past few weeks small vesicles had formed along the sides of her fingers. Some had ruptured and become scaly papules. Her fingers were extremely pruritic, and she said it was " driving her crazy. " Can you diagnose the patient? (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 20, 2018 Category: Dermatology Source Type: news

Vitamin deficiency we are all born with
I’ve admired Linus Pauling for years. In 1976, the Nobel Prize-winning chemist gave mega doses of vitamin C to 100 “untreatable” cancer patients. He then compared these so-called terminal patients to patients with the same kind of cancer who didn’t get vitamin C. The patients who received the traditional cancer treatment lived for an average of six months. Pauling’s patients lived — on average — for six years. You’d think that the medical community would have heralded Pauling’s research as a huge breakthrough in cancer treatment. But they didn’t. And they still don’t. Despite groundbreaking research...
Source: Al Sears, MD Natural Remedies - January 17, 2018 Category: Complementary Medicine Authors: Cathy Card Tags: Health Natural Cures Nutrition anti-cancer leukemia vitamin vitamin C Source Type: news

ClearLine MD(TM) Secures $5.5MM Funding for Commercialization of ClearLine IV(TM)
WOBURN, Mass., Jan. 9, 2018 -- (Healthcare Sales & Marketing Network) -- ClearLine MD, a medical device company focused on reducing the impact of iatrogenic Air Burden to patients and improving the safety and effectiveness of intravenous (IV) therapy, tod... Devices, Venture Capital ClearLine MD, ClearLine, iatrogenic Air, intravenous (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 9, 2018 Category: Pharmaceuticals Source Type: news